Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Future pharmacological treatments for substance use disorders
Ariadna Forray, Mehmet Sofuoglu
British Journal of Clinical Pharmacology (2012) Vol. 77, Iss. 2, pp. 382-400
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

The Main Molecular Mechanisms Underlying Methamphetamine- Induced Neurotoxicity and Implications for Pharmacological Treatment
Xue Yang, Yong Wang, Qiyan Li, et al.
Frontiers in Molecular Neuroscience (2018) Vol. 11
Open Access | Times Cited: 185
Supramolecular hosts as in vivo sequestration agents for pharmaceuticals and toxins
Chun‐Lin Deng, Steven Murkli, Lyle Isaacs
Chemical Society Reviews (2020) Vol. 49, Iss. 21, pp. 7516-7532
Open Access | Times Cited: 115
Marijuana: Current Concepts†
Donald E. Greydanus, Elizabeth K. Hawver, Megan M. Greydanus, et al.
Frontiers in Public Health (2013) Vol. 1
Open Access | Times Cited: 111
Cognitive Function as a Transdiagnostic Treatment Target in Stimulant Use Disorders
Mehmet Sofuoglu, Elise E. DeVito, Andrew J. Waters, et al.
Journal of Dual Diagnosis (2016) Vol. 12, Iss. 1, pp. 90-106
Open Access | Times Cited: 90
Pharmacological treatments for methamphetamine addiction: current status and future directions
Javier Ballester, Gerald Valentine, Mehmet Sofuoglu
Expert Review of Clinical Pharmacology (2016), pp. 1-10
Closed Access | Times Cited: 88
Carbonic Anhydrase Activators for Neurodegeneration: An Overview
Valeria Poggetti, Silvia Salerno, Emma Baglini, et al.
Molecules (2022) Vol. 27, Iss. 8, pp. 2544-2544
Open Access | Times Cited: 31
The vagus nerve mediates the suppressing effects of peripherally administered oxytocin on methamphetamine self-administration and seeking in rats
Nicholas A. Everett, A Turner, Priscila A. Costa, et al.
Neuropsychopharmacology (2020) Vol. 46, Iss. 2, pp. 297-304
Open Access | Times Cited: 46
A Supramolecular Antidote to Macromolecular Toxins Prepared through Coassembly of Macrocyclic Amphiphiles
Yu‐Chen Pan, Yu‐Xin Yue, Xin‐Yue Hu, et al.
Advanced Materials (2021) Vol. 33, Iss. 40
Closed Access | Times Cited: 34
Changes and Future Directions in Liver Transplantation in the United States
Francis Spitz, Stalin Dharmayan, Jason Mial-Anthony, et al.
Livers (2025) Vol. 5, Iss. 1, pp. 7-7
Open Access
Quality indicators for substance use disorder care: a scoping review protocol
Tom Richards, Julia Kirkham, Diane Lorenzetti, et al.
BMJ Open (2025) Vol. 15, Iss. 3, pp. e085216-e085216
Open Access
Addiction disorders: a need for change. Proposal for a new management. Position paper of SIA, Italian Society on Alcohol
Gianni Testino, Luigi Carlo Bottaro, Valentino Patussi, et al.
Minerva Medica (2018) Vol. 109, Iss. 5
Closed Access | Times Cited: 43
Amphetamine elevates nucleus accumbens dopamine via an action potential‐dependent mechanism that is modulated by endocannabinoids
Dan P. Covey, Kendra D. Bunner, Douglas R. Schuweiler, et al.
European Journal of Neuroscience (2016) Vol. 43, Iss. 12, pp. 1661-1673
Open Access | Times Cited: 42
A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction
Richard L. Bell, Sheketha R. Hauser, Zachary A. Rodd, et al.
International review of neurobiology (2016), pp. 179-261
Open Access | Times Cited: 42
Involvement of C/EBPβ-related signaling pathway in methamphetamine-induced neuronal autophagy and apoptosis
Enping Huang, Hongyan Huang, Tianshan Guan, et al.
Toxicology Letters (2019) Vol. 312, pp. 11-21
Closed Access | Times Cited: 35
Cross talk about the role of Neuropeptide Y in CNS disorders and diseases
Rajeshwari Bale, Gaurav Doshi
Neuropeptides (2023) Vol. 102, pp. 102388-102388
Closed Access | Times Cited: 12
Psychostimulants
Andrew C. McCreary, Christian P. Müller, Małgorzata Filip
International review of neurobiology (2015), pp. 41-83
Closed Access | Times Cited: 39
Cognitive dysfunction in individuals with cocaine use disorder: Potential moderating factors and pharmacological treatments.
James J. Mahoney
Experimental and Clinical Psychopharmacology (2018) Vol. 27, Iss. 3, pp. 203-214
Open Access | Times Cited: 37
Changes in Neuropsychological Status during the Initial Phase of Abstinence in Alcohol Use Disorder: Neurocognitive Impairment and Implications for Clinical Care
Kyler Mulhauser, Jeremiah Weinstock, Phillip Ruppert, et al.
Substance Use & Misuse (2018) Vol. 53, Iss. 6, pp. 881-890
Closed Access | Times Cited: 26
Advances and challenges in pharmacotherapeutics for amphetamine-type stimulants addiction
Danni Cao, Jingjing Shi, Wei Hao, et al.
European Journal of Pharmacology (2016) Vol. 780, pp. 129-135
Closed Access | Times Cited: 24
Mechanistic insights into the efficacy of memantine in treating certain drug addictions
Chiara Montemitro, Alexanndra Angebrandt, Tzu‐Yun Wang, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2021) Vol. 111, pp. 110409-110409
Open Access | Times Cited: 18
Host-guest chemistry for the design of drug antagonists
Shang-Bo Yu, Wei Zhou, Jia Tian, et al.
Scientia Sinica Chimica (2023) Vol. 53, Iss. 12, pp. 2345-2356
Closed Access | Times Cited: 7
Need for Care and Life Satisfaction in Adult Substance Use Disorder Patients With and Without Attention Deficit Hyperactivity Disorder (ADHD) or Autism Spectrum Disorder (ASD)
Linda Kronenberg, Peter J. J. Goossens, Derk M. van Etten, et al.
Perspectives In Psychiatric Care (2014) Vol. 51, Iss. 1, pp. 4-15
Closed Access | Times Cited: 22
The Relationship Between Serum Cytokine Levels and the Degree of Psychosis and Cognitive Impairment in Patients With Methamphetamine-Associated Psychosis in Chinese Patients
Xue Yang, Hui Zhao, Xuebing Liu, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 18
Lurasidone use in Cannabis-Induced Psychosis: A Novel Therapeutic Strategy and Clinical Considerations in Four Cases Report
Valerio Ricci, Giovanni Martinotti, Domenico De Berardis, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 23, pp. 16057-16057
Open Access | Times Cited: 11
Modafinil augments brain activation associated with reward anticipation in the nucleus accumbens
Takuya Funayama, Yumiko Ikeda, Amane Tateno, et al.
Psychopharmacology (2014) Vol. 231, Iss. 16, pp. 3217-3228
Closed Access | Times Cited: 21
Page 1 - Next Page

Scroll to top